Nanobiotix S.A. (NBTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -16.01M | -17.41M | -13.71M | -5.84M | 4.8M | -17.27M | -19.59M | -17.52M | -14.8M | -15.07M | -14.66M | -12.88M |
| Operating CF Margin % | -532.81% | -65.36% | 83.23% | -62.83% | 14.58% | -524.6% | -568.18% | -1318.13% | -1114.53% | -1142.61% | -1671.49% | -889.43% |
| Operating CF Growth % | -16.74% | -198.34% | -385.79% | 66.22% | 124.5% | 1.39% | -32.32% | -16.24% | -0.97% | -17.02% | 26.13% | 39.6% |
| Net Income | -18.58M | -5.38M | -46.26M | -21.87M | -11.6M | -28.1M | -30.68M | -26.36M | -16.58M | -30.42M | -13.01M | -20.58M |
| Depreciation & Amortization | 695K | 800K | 835K | 786K | 772K | 741K | 754K | 746K | 759K | 801K | 848K | 906K |
| Stock-Based Compensation | 1.38M | 2.16M | 2.36M | 1.94M | 1.95M | 1.35M | 1.91M | 1.36M | 1.8M | 1.4M | 1.38M | 1.54M |
| Deferred Taxes | 3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.28M | -15.37M | 26.73M | 15.8M | 12.4M | 10.38M | 10.2M | 5.57M | -4.97M | 22.03M | -7.84M | 2.46M |
| Working Capital Changes | -3.78M | 383K | 2.62M | -2.49M | 1.27M | -1.64M | -1.77M | 1.17M | 4.19M | -8.88M | 3.96M | 2.79M |
| Change in Receivables | 712K | 1.14M | 144K | -2.21M | 183K | -989K | 137K | -238K | 0 | 62K | -12K | -39K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -416K | -162K | -455K | -500K | -22K | -327K | 85K | 53K | -192K | -50K | -29K | -83K |
| Capital Expenditures | -388K | -150K | -357K | -489K | -5K | -323K | -13K | -79K | -183K | -45K | -39K | -57K |
| CapEx % of Revenue | 12.91% | 0.56% | -2.17% | 5.26% | 0.02% | 9.81% | 0.38% | 5.94% | 13.78% | 3.41% | 4.45% | 3.94% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -28K | -12K | -98K | -11K | -17K | -4K | 98K | 132K | -9K | -5K | 10K | -26K |
| Cash from Financing | 40.25M | -2.83M | -2.48M | -2.65M | 48.91M | -2.14M | -2.15M | -3.51M | -3.48M | -1.7M | 107.36M | 4.4M |
| Debt Issued (Net) | 40.68M | -2.49M | 0 | -2.05M | 0 | -1.73M | 0 | -3.02M | 0 | -894K | 0 | 5.18M |
| Equity Issued (Net) | 1.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.97M | -336K | -2.48M | -609K | 48.91M | -405K | -2.15M | -481K | -3.48M | -809K | 107.36M | -775K |
| Net Change in Cash | 23.93M | -20.92M | -16.6M | -8.95M | 53.65M | -19.76M | -21.63M | -20.9M | -18.41M | -16.82M | 92.56M | -8.5M |
| Free Cash Flow | -16.41M | -17.56M | -14.07M | -6.33M | 4.79M | -17.6M | -19.6M | -17.6M | -14.98M | -15.12M | -14.7M | -12.94M |
| FCF Margin % | -545.99% | -65.92% | 85.39% | -68.09% | 14.56% | -534.41% | -568.55% | -1324.08% | -1128.31% | -1146.02% | -1675.94% | -893.37% |
| FCF Growth % | -16.59% | -177.64% | -393.53% | 64.06% | 124.46% | -0.01% | -30.79% | -16.41% | -1.95% | -16.85% | 27.92% | 40.85% |
| FCF per Share | -0.34 | -0.37 | -0.30 | -0.13 | 0.12 | -0.50 | -0.56 | -0.51 | -0.43 | -0.44 | -0.53 | -0.57 |
| FCF Conversion (FCF/Net Income) | 0.86x | 3.23x | 0.30x | 0.27x | -0.41x | 0.61x | 0.64x | 0.66x | 0.89x | 0.50x | 1.13x | 0.63x |
| Interest Paid | -336K | 336K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |